A new study published in JAMA finds that people with public insurance say they fare better than people with private insurance when it comes to access to care, costs and satisfaction. The study...
Diane Archer
Coronavirus: Pfizer puts profits ahead of public health
What would a corporate COVID-19 vaccine manufacturer do in the face of a pandemic? You guessed it: Use its power to put maximizing profits ahead of the public health. And, that’s just what...
Biden administration aims to stop Pharma from preventing drug...
ABCNews.com reports on a Biden administration effort to ensure states can legally import drugs from abroad. You might have guessed that big Pharma is opposing drug importation by states. In this...
Five reasons to eat avocados
Avocados are in season and there’s every reason to eat them. CNN reports on five health benefits of avocados that you likely did not know. And, there are so many great ways to enjoy them. Here...
Beware of hospitals that charge for parking
Rebecca Ritzel reports for Kaiser Health News on hospitals that charge steep prices for parking. Consequently, patients with costly conditions who are repeat hospital visitors don’t only have...
Dental fraud: How to protect yourself
Daryl Austin writes for Kaiser Health News about dental fraud. Yes, dentists sometimes identify problems with your teeth in order to be able to perform services that are in fact unnecessary...
Coronavirus: Antibody test won’t always show whether the...
The COVID-19 vaccine is helping tens of millions of people, but it does not always offer protection to people with cancer. Stat News reports that people with cancer do not always generate sufficient...
More hospitals providing care at home
Julie Appleby reports for Kaiser Health News that, down the road, a lot of hospital care may be able to happen in the comfort of your home. Already, Medicare pays for some hospital care at home. And...
Coronavirus: Physical therapy can help reverse the toll of...
There’s a lot of focus on the disproportionately high number of older adults who contracted and died of COVID-19. There’s been far less focus on the number of older adults who have...
AbbVie gets a scolding from Congress but can keep raising prices
Richard Gonzalez, AbbVie’s CEO, has been hard at work raising the price of its best-selling overpriced drug, Humira, along with other drugs. But, instead of passing legislation that benchmarks...